ONDCP Policy Statement on Priorities

On April 1, the Office of National Drug Control Policy (ONDCP) released its statement of drug policy priorities for the first year of the Biden-Harris Administration. These policy priorities will hopefully save lives and address the challenges New Jersey and the rest of the country are facing due to the opioid epidemic. Some of the highlights of these policies include:

  • Expanding access to evidence-based treatment
  • Advancing racial equity issues in the approach to drug policy
  • Enhancing evidence-based harm reduction efforts
  • Reducing the supply of illicit substances
  • Advancing recovery-ready workplaces and expanding the addiction workforce
  • Expanding access to recovery supports services

The Covid-19 pandemic has greatly affected those who are in recovery or treatment for substance use disorder. I am hopeful that the current administration and the ONDCP will make sure that those who suffer from substance use disorder will continue to be a top priority.

Additionally, I am also urging you join PDFNJ in supporting the Opioid Patient's Right To Know Act. This federal act would create a grant program to incentivize states to require prescribers to discuss the addictive qualities of opioids. Click here to easily sign up for a letter to be automatically sent to your Congressperson.  It only takes a couple of minutes and can hopefully save lives.

Continued wishes to safe and well.

Blog Updates

Enter your email address and we'll send you an email each time we post something new.